Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Gene | CHEK2 |
| Variant | F169L |
| Impact List | missense |
| Protein Effect | loss of function - predicted |
| Gene Variant Descriptions | CHEK2 F169L lies within the FHA domain of the Chek2 protein (UniProt.org). F169L results in Chek2 autophosphorylation similar to wild-type in culture (PMID: 37449874), but reduced Kap1 phosphorylation at serine (S)-473 upon ionizing radiation in cell culture (PMID: 34903604) and intermediate Kap1 phosphorylation in culture (PMID: 37449874), and therefore, is predicted to lead to a loss of Chek2 protein function. |
| Associated Drug Resistance | |
| Category Variants Paths |
CHEK2 mutant CHEK2 inact mut CHEK2 F169L |
| Transcript | NM_007194.4 |
| gDNA | chr22:g.28725064A>G |
| cDNA | c.505T>C |
| Protein | p.F169L |
| Source Database | RefSeq |
| Genome Build | GRCh38/hg38 |
| Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
|---|---|---|---|---|---|
| NM_007194.4 | chr22:g.28725064A>G | c.505T>C | p.F169L | RefSeq | GRCh38/hg38 |
| NM_145862.2 | chr22:g.28725064A>G | c.505T>C | p.F169L | RefSeq | GRCh38/hg38 |
| NM_145862.2 | chr22:g.28725064A>G | c.505T>C | p.F169L | RefSeq | GRCh38/hg38 |
| NM_007194.3 | chr22:g.28725064A>G | c.505T>C | p.F169L | RefSeq | GRCh38/hg38 |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|